| CAD/SOAR domain | CRAC activation domain/STIM1–Orai1 activating region domain |
| CC domains | Conserved cytosolic coiled-coil domains |
| CCE | Capacitive calcium entry |
| cEFh | Canonical EF-hand |
| CIRB | Calmodulin/inositol 1,4,5-trisphosphate receptor-binding |
| CRAC | Ca2+-release-activated-Ca2+ channel |
| CTID | C-terminal inhibitory domain |
| DGC | Dystrophin glycoprotein complex |
| DHPR | Dihydropyridine receptor |
| DMD | Duchenne muscular dystrophy |
| EC coupling | Excitation–contraction coupling |
| ECCE | Excitation-coupled Ca2+ entry |
| ER/SR | Endoplasmic/sarcoplasmic reticulum |
| ERK1/2 | Extracellular signal-regulated kinase 1 and 2 |
| ETON | Extended transmembrane Orai1 N-terminal |
| GHS | Growth hormone secretagogues |
| GPCRs | Plasma membrane G protein-coupled receptors |
| IP3 | Inositol 1,4,5-triphosphate |
| IP3R | Inositol 1,4,5-triphosphate receptor |
| MAP kinases | Mitogen-activated protein kinases |
| MEF2 | Myocyte enhancer factor-2 |
| ncEFh | Non-canonical EF-hand |
| nNOS | Nitric oxide synthase |
| PIP2 | Phosphatidylinositol biphosphate |
| PLC | Phospholipase C |
| PM | Plasma membrane |
| PMCAs | Plasma membrane calcium ATPases |
| RYR1 | Ryanodine receptor type 1 |
| SAM | Sterile motif |
| SARAF | SOCE-associated regulatory factor |
| SCID | Severe combined immunodeficiency |
| SERCA | Sarco-/endoplasmic reticular calcium ATPase |
| SOAR | STIM1–Orai1 activating region |
| SOCCs | Store-operated-calcium channels |
| SOCE | Store-operated Ca2+ entry |
| STIM1 | Stromal-interacting molecule-1 |
| STRMK | Stormorken Syndrome |
| TAM | Tubular aggregate myopathy |
| TAs | Tubular aggregates |
| tBHQ | 2,5-di-(tert-butyl)-1,4-benzohydroquinone |
| TM | Transmembrane helices |
| TRPCs | Transient receptor potential canonical channels |